Filed: 8/14/2025ACC: 0000921895-25-002281
📋 What this filing means
BVF INC/IL filed this quarterly 13F‑HR report disclosing 44 equity positions with a total reported market value of $2.80B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
44
Positions
$2.80B
Total AUM (reported)
193.64M
Total Shares
Allocation by class
COM$1.48B53.0%
CLASS A ORD$932.26M33.3%
COM NEW$158.56M5.7%
ORDINARY SHARES$107.61M3.8%
SHS$40.24M1.4%
ADS$39.47M1.4%
SPONSORED ADS$36.74M1.3%
Portfolio Concentration
Top 3$1.36B48.4%
4–10$797.00M28.5%
11–25$500.07M17.9%
Rest$146.37M5.2%
Top 3 weight
48.4%
Top 10 weight
76.9%
Voting Authority Distribution
Total shares with voting rights: 193.64M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
193.64M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other44
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings44
Rows:
MOONLAKE IMMUNOTHERAPEUTICS
DFNDShares19.75M
TypeSH
Market value$932.26M
33.31%
Sole
0.00
Shared
19.75M
None
0.00
KYMERA THERAPEUTICS INC
DFNDShares5.50M
TypeSH
Market value$240.14M
8.58%
Sole
0.00
Shared
5.50M
None
0.00
REVOLUTION MEDICINES INC
DFNDShares4.98M
TypeSH
Market value$183.30M
6.55%
Sole
0.00
Shared
4.98M
None
0.00
PROTAGONIST THERAPEUTICS INC
DFNDShares3.21M
TypeSH
Market value$177.47M
6.34%
Sole
0.00
Shared
3.21M
None
0.00
AXSOME THERAPEUTICS INC
DFNDShares1.69M
TypeSH
Market value$176.44M
6.30%
Sole
0.00
Shared
1.69M
None
0.00
MIRUM PHARMACEUTICALS INC
DFNDShares2.76M
TypeSH
Market value$140.52M
5.02%
Sole
0.00
Shared
2.76M
None
0.00
GH RESEARCH PLC
DFNDShares8.83M
TypeSH
Market value$107.61M
3.84%
Sole
0.00
Shared
8.83M
None
0.00
IONIS PHARMACEUTICALS INC
DFNDShares1.91M
TypeSH
Market value$75.60M
2.70%
Sole
0.00
Shared
1.91M
None
0.00
XOMA ROYALTY CORPORATION
DFNDShares2.59M
TypeSH
Market value$65.28M
2.33%
Sole
0.00
Shared
2.59M
None
0.00
ZYMEWORKS INC
DFNDShares4.31M
TypeSH
Market value$54.08M
1.93%
Sole
0.00
Shared
4.31M
None
0.00
SEPTERNA INC
DFNDShares4.40M
TypeSH
Market value$46.47M
1.66%
Sole
0.00
Shared
4.40M
None
0.00
CELCUITY INC
DFNDShares3.47M
TypeSH
Market value$46.27M
1.65%
Sole
0.00
Shared
3.47M
None
0.00
KURA ONCOLOGY INC
DFNDShares7.75M
TypeSH
Market value$44.74M
1.60%
Sole
0.00
Shared
7.75M
None
0.00
CULLINAN THERAPEUTICS INC
DFNDShares5.75M
TypeSH
Market value$43.30M
1.55%
Sole
0.00
Shared
5.75M
None
0.00
AC IMMUNE SA
DFNDShares19.82M
TypeSH
Market value$40.24M
1.44%
Sole
0.00
Shared
19.82M
None
0.00
CIDARA THERAPEUTICS INC
DFNDShares786.39K
TypeSH
Market value$38.31M
1.37%
Sole
0.00
Shared
786.39K
None
0.00
TYRA BIOSCIENCES INC
DFNDShares3.94M
TypeSH
Market value$37.75M
1.35%
Sole
0.00
Shared
3.94M
None
0.00
STRUCTURE THERAPEUTICS INC
DFNDShares1.77M
TypeSH
Market value$36.74M
1.31%
Sole
0.00
Shared
1.77M
None
0.00
IMMUNOCORE HLDGS PLC
DFNDShares1.02M
TypeSH
Market value$32.14M
1.15%
Sole
0.00
Shared
1.02M
None
0.00
MONTE ROSA THERAPEUTICS INC
DFNDShares5.66M
TypeSH
Market value$25.53M
0.91%
Sole
0.00
Shared
5.66M
None
0.00
FOGHORN THERAPEUTICS INC
DFNDShares5.30M
TypeSH
Market value$24.92M
0.89%
Sole
0.00
Shared
5.30M
None
0.00
OLEMA PHARMACEUTICALS INC
DFNDShares5.30M
TypeSH
Market value$22.56M
0.81%
Sole
0.00
Shared
5.30M
None
0.00
CRESCENT BIOPHARMA INC.
DFNDShares1.39M
TypeSH
Market value$22.40M
0.80%
Sole
0.00
Shared
1.39M
None
0.00
XENCOR INC
DFNDShares2.74M
TypeSH
Market value$21.54M
0.77%
Sole
0.00
Shared
2.74M
None
0.00
4D MOLECULAR THERAPEUTICS IN
DFNDShares4.63M
TypeSH
Market value$17.17M
0.61%
Sole
0.00
Shared
4.63M
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MOONLAKE IMMUNOTHERAPEUTICSDFND | CLASS A ORD | 19.75M | SH | $932.26M 33.31% | 0.00 | 19.75M | 0.00 |
KYMERA THERAPEUTICS INCDFND | COM | 5.50M | SH | $240.14M 8.58% | 0.00 | 5.50M | 0.00 |
REVOLUTION MEDICINES INCDFND | COM | 4.98M | SH | $183.30M 6.55% | 0.00 | 4.98M | 0.00 |
PROTAGONIST THERAPEUTICS INCDFND | COM | 3.21M | SH | $177.47M 6.34% | 0.00 | 3.21M | 0.00 |
AXSOME THERAPEUTICS INCDFND | COM | 1.69M | SH | $176.44M 6.30% | 0.00 | 1.69M | 0.00 |
MIRUM PHARMACEUTICALS INCDFND | COM | 2.76M | SH | $140.52M 5.02% | 0.00 | 2.76M | 0.00 |
GH RESEARCH PLCDFND | ORDINARY SHARES | 8.83M | SH | $107.61M 3.84% | 0.00 | 8.83M | 0.00 |
IONIS PHARMACEUTICALS INCDFND | COM | 1.91M | SH | $75.60M 2.70% | 0.00 | 1.91M | 0.00 |
XOMA ROYALTY CORPORATIONDFND | COM NEW | 2.59M | SH | $65.28M 2.33% | 0.00 | 2.59M | 0.00 |
ZYMEWORKS INCDFND | COM | 4.31M | SH | $54.08M 1.93% | 0.00 | 4.31M | 0.00 |
SEPTERNA INCDFND | COM | 4.40M | SH | $46.47M 1.66% | 0.00 | 4.40M | 0.00 |
CELCUITY INCDFND | COM | 3.47M | SH | $46.27M 1.65% | 0.00 | 3.47M | 0.00 |
KURA ONCOLOGY INCDFND | COM | 7.75M | SH | $44.74M 1.60% | 0.00 | 7.75M | 0.00 |
CULLINAN THERAPEUTICS INCDFND | COM | 5.75M | SH | $43.30M 1.55% | 0.00 | 5.75M | 0.00 |
AC IMMUNE SADFND | SHS | 19.82M | SH | $40.24M 1.44% | 0.00 | 19.82M | 0.00 |
CIDARA THERAPEUTICS INCDFND | COM NEW | 786.39K | SH | $38.31M 1.37% | 0.00 | 786.39K | 0.00 |
TYRA BIOSCIENCES INCDFND | COM | 3.94M | SH | $37.75M 1.35% | 0.00 | 3.94M | 0.00 |
STRUCTURE THERAPEUTICS INCDFND | SPONSORED ADS | 1.77M | SH | $36.74M 1.31% | 0.00 | 1.77M | 0.00 |
IMMUNOCORE HLDGS PLCDFND | ADS | 1.02M | SH | $32.14M 1.15% | 0.00 | 1.02M | 0.00 |
MONTE ROSA THERAPEUTICS INCDFND | COM | 5.66M | SH | $25.53M 0.91% | 0.00 | 5.66M | 0.00 |
FOGHORN THERAPEUTICS INCDFND | COM | 5.30M | SH | $24.92M 0.89% | 0.00 | 5.30M | 0.00 |
OLEMA PHARMACEUTICALS INCDFND | COM | 5.30M | SH | $22.56M 0.81% | 0.00 | 5.30M | 0.00 |
CRESCENT BIOPHARMA INC.DFND | COM | 1.39M | SH | $22.40M 0.80% | 0.00 | 1.39M | 0.00 |
XENCOR INCDFND | COM | 2.74M | SH | $21.54M 0.77% | 0.00 | 2.74M | 0.00 |
4D MOLECULAR THERAPEUTICS INDFND | COM | 4.63M | SH | $17.17M 0.61% | 0.00 | 4.63M | 0.00 |
Page 1 of 2